Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Population Based Studies of Epilepsy Prevalence and Incidence, Program Announcement Number PEP 2006-R-03, 18102 [E6-5170]

Download as PDF 18102 Federal Register / Vol. 71, No. 68 / Monday, April 10, 2006 / Notices Dated: April 4, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–5172 Filed 4–7–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Determinants of Receiving Radiation Therapy after Breast Conserving Surgery Among Low-Income Women, Program Announcement Number PEP 2006–R– 09 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: wwhite on PROD1PC65 with NOTICES Name: Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Determinants of Receiving Radiation Therapy after Breast Conserving Surgery Among Low-Income Women, Program Announcement Number PEP 2006– R–09. Time and Date: 1 p.m.–3 p.m., May 15, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduct expert review of scientific and technical merit of research applications in response to Determinants of Receiving Radiation Therapy after Breast Conserving Surgery Among LowIncome Women, Program Announcement Number PEP 2006–R–09. For Further Information Contact: Felix Rogers, PhD, M.P.H., Scientific Review Administrator, CDC, 1600 Clifton Road NE., Mailstop E05, Atlanta, GA 30333, Telephone 404–639–6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Establishing a Surveillance System for Chronic Kidney Disease in the US, Program Announcement Number PEP 2006–R– 08 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Population Based Studies of Epilepsy Prevalence and Incidence, Program Announcement Number PEP 2006–R– 03 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Establishing a Surveillance System for Chronic Kidney Disease in the US, Program Announcement Number PEP 2006–R–08. Time and Date: 1 p.m.–2 p.m., May 17, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduct expert review of scientific and technical merit of research applications in response to Impact of DRG 559 on Costs, Quality and Patient Outcomes of Stroke Care, Program Announcement Number PEP 2006–R–08. For Further Information Contact: Felix Rogers, PhD, M.P.H., Scientific Review Administrator, CDC, 1600 Clifton Road NE, Mailstop E05, Atlanta, GA 30333, Telephone (404) 639–6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Population Based Studies of Epilepsy Prevalence and Incidence, Program Announcement Number PEP 2006–R–03. Time and Date: 2 p.m.–4 p.m., May 16, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Population Based Studies of Epilepsy Prevalence and Incidence, Program Announcement Number PEP 2006–R–03. For Further Information Contact: Felix Rogers, Ph.D., M.P.H., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop E05, Atlanta, GA 30333, Telephone 404–639–6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5167 Filed 4–7–06; 8:45 am] Dated: April 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5170 Filed 4–7–06; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P Dated: April 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5173 Filed 4–7–06; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 18:48 Apr 07, 2006 Jkt 208001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 71, Number 68 (Monday, April 10, 2006)]
[Notices]
[Page 18102]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5170]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Population Based Studies of Epilepsy Prevalence 
and Incidence, Program Announcement Number PEP 2006-R-03

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Population Based Studies of Epilepsy 
Prevalence and Incidence, Program Announcement Number PEP 2006-R-03.
    Time and Date: 2 p.m.-4 p.m., May 16, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Population Based Studies of Epilepsy Prevalence and Incidence, 
Program Announcement Number PEP 2006-R-03.
    For Further Information Contact: Felix Rogers, Ph.D., M.P.H., 
Scientific Review Administrator, CDC, 1600 Clifton Road, NE., 
Mailstop E05, Atlanta, GA 30333, Telephone 404-639-6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 4, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-5170 Filed 4-7-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.